Pfizer Inc at JPMorgan U.S. All Stars Conference Transcript
We're ready to go. So good morning, everybody. I'm Chris Schott, the pharma analyst here at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Pfizer. From the company, we have Dave Denton, the company's CFO, and before we jump into, which will be, I'm sure, a very interesting discussion. We have Ronen, from the IR team, read disclosure here, and then we'll dive into the conversation from there.
Thank you, Chris. I just wanted to inform you that we are going to be making some forward-looking statements. And then we're going to be making those looking forward statements that are true for today. And if you have any additional questions, on the forward-looking statements, please see the relevant sectors in our SEC filing on the Forms 10-Q and 10-K. Thank you.
Questions & Answers
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |